BIOTINIDASE DEFICIENCY IN JUVENILE MULTIPLE CARBOXYLASE DEFICIENCY by Thoene, Jess G. & Wolf, Barry
398
BIOTINIDASE DEFICIENCY IN JUVENILE MULTIPLE
CARBOXYLASE DEFICIENCY
SIR,-Juvenile biotin-responsive multiple carboxylase deficiency
(MCD) is characterised by onset, after the neonatal period, of
lacticacidosis, alopecia, ataxia, seizures, and erythematous rash.
Plasma and urinary biotin concentrations are subnormal and all
abnormal clinical and biochemical findings are reversed by
d-biotin. This form of MCD is thought to be caused by a defect in
biotin absorption or transport;2,3 the neonatal form is due to
defective biotin holocarboxylase synthetase activity.4 Recently,
deficient activity of serum biotindase was demonstrated in several
patients with the juvenile phenotype, and intermediate activities
were found in the serum of their parents. This suggests that
biotinidase deficiency is the primary enzyme defect in some patients
with juvenile MCD.’’ Moreover, patients with biotinidase
deficiency whose tissues are biotin-depleted might fail to exhibit a
normal plasma biotin response when given oral biotin, explainable
by the rapid entry of biotin into the tissues. To test this hypothesis
we evaluated the plasma biotin response after administration of a
small amount of biotin to a patient with biotinidase deficiency
whose initial plasma biotin concentration was not subnormal.
This 6V2-year-old girl with biotin-responsive MCD1 and defective
absorption of biotin had normal fibroblast holocarboxylase
Response of plasma biotin to ingestion of 5 JAg/kg of biotin when
patient was not biotin deficient.
synthetase activity. She has been on oral biotin (10 mg daily) since
31 months of age and at the time of this study she weighed 25 kg
(90th percentile) and was 118 cm tall (50th percentile). 8 days
before this study, while the child continued to ingest a normal diet,
biotin supplements were stopped. She then received a low oral dose of
biotin (5 pg/kg) and her plasma biotin concentrations were measured
over 24 h. Urine was collected to determine renal biotin clearance
and fractional biotin excretion. Biotin concentrations were
measured by competitive protein binding assay. 7 Biotinidase
activity was assessed colorimetrically by measuring
p-aminobenzoate liberation from N-biotinyl-p-aminobenzoate.8
Previously,2 after 42 days of biotin deprivation, an erythematous
rash had developed with very low plasma biotin concentration (143
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BIOTINIDASE ACTIVITY IN PATIENT AND MOTHER
pg/ml, mean normal concentration 520&plusmn;220 SD), and she had
excreted in her urine only 4-3-15% of the ingested biotin dose in 24
h (normal value 25-28%) and had a renal biotin clearance of 54-9 
ml/min/1-73 m2 (normal 38-8&plusmn;6-5). These findings were
interpreted as indicating that biotin absorption both in the intestinal
tract and in the renal tubules was abnormal. However, when the
patient was tested at a time when her tissues were biotin replete
(achieved by withholding biotin for only 8 days) her biotin response
was normal. The figure shows that at the start of the study her
plasma biotin was slightly above normal range (2720 pg/ml).
However, 1 h after ingestion of 5 J.lg/kg of biotin, her plasma biotin
concentration rose to 5650 pg/ml, as in similarly treated biotin-
replete controls. Biotin clearance was also normal (34-4 4
ml/min/1’ 73 m2). The fraction of biotin excreted in her urine in the
24 h after the biotin dose was 50’ 8%, twice as high as the amount
excreted by the controls and more than three times her previous
maximum excretion (15%).
Biotinidase activity in the patient’s serum was undetectable
(table). The mother, who does not have clinical biotin deficiency,
had 46% of mean normal biotinidase activity and a plasma biotin of
248 pg/ml, which is below normal.
Dietary biotin exists primarily as biotinyl groups linked to the
E-amino groups of lysine residues of proteins.9 Biotinidase
hydrolyses this bond, releasing free biotin. Biotinidase activity is
widely distributed, particularly in liver, kidney, serum, and gut
mucosa.9 Although this enzyme’s primary site of action on dietary
protein is not known, deficiency could impair ability to maintain
normal body stores of free biotin, leading to a hypobiotinaemic
state. Whether biotinidase is also involved in the absorption of free
biotin is not known.
The patient’s normal plasma biotin response to the ingestion of
5pg/kg of biotin when her tissues were replete with biotin, but her
failure to respond when she was biotin deficient is probably caused
by rapid entry of biotin into the depleted tissues. Similar results
have been obtained in thiamine-deficient patients. 10,1 Rapid
saturation of deficient tissues with the vitamin results in subnormal
increases in the plasma concentrations, mimicking an apparent
defect in intestinal absorption.
Juvenile MCD probably results from impaired generation of free
biotin from biotinyl residues of dietary protein. Presumably the
child is born with normal stores of free biotin but, once dependent
on dietary protein-bound biotin, a child with biotinidase deficiency
would become hypobiotinaemic and clinical symptoms of biotin
deficiency would ensue. This mechanism could account for the late
onset of acute symptoms (as opposed to the neonatal onset of
symptoms in holocarboxylase synthetase deficiency) and, for some
of the clinical variability.
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